The role of N6-methyladenosine modification in the life cycle and disease pathogenesis of hepatitis B and C viruses

Geon-Woo Kim,Aleem Siddiqui
DOI: https://doi.org/10.1038/s12276-021-00581-3
2021-03-01
Abstract:Abstract N6-methyladenosine (m 6 A) is the most prevalent modification of mammalian cellular RNAs. m 6 A methylation is linked to epigenetic regulation of several aspects of gene expression, including RNA stability, splicing, nuclear export, RNA folding, and translational activity. m 6 A modification is reversibly catalyzed by methyltransferases (m 6 A writers) and demethylases (m 6 A erasers), and the dynamics of m 6 A-modified RNA are regulated by m 6 A-binding proteins (m 6 A readers). Recently, several studies have shown that m 6 A methylation sites have been identified in hepatitis B virus (HBV) transcripts and the hepatitis C virus (HCV) RNA genome. Here, we review the role of m 6 A modification in HBV/HCV replication and its contribution to liver disease pathogenesis. A better understanding of the functions of m 6 A methylation in the life cycles of HBV and HCV is required to establish the role of these modifications in liver diseases associated with these viral infections.
biochemistry & molecular biology,medicine, research & experimental
What problem does this paper attempt to address?